The Global Brain Cancer Therapeutics Market size was valued at around USD 3.3 billion in 2024 and is projected to reach USD 5.1 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 7.3% during the forecast period, i.e., 2025-30.
Global Brain Cancer Therapeutics Market Driver:
Increasing Incidence of Brain Tumors – The growing number of patients suffering from brain tumors is the primary growth driver. According to the American Cancer Society, about 25,400 people are suffering from malignant tumors of the brain or spinal cord, with around 14,420 males and 10,980 females diagnosed. This number takes the lead over non-cancer tumors. By age 40 and above, there were about 79,340 patients diagnosed with primary brain tumors, while around 5,230 people under 20 years of age were diagnosed with central nervous system (CNS) tumors. This creates an intensive requirement for the innovation of therapies such as targeted therapies and immunotherapy, which aim to improve patient outcomes by targeting specific cancer cells and boosting the body’s immune response against tumors.
The increasing incidence directly fuels the need for continued development, driving growth in the brain tumor diagnosis and treatment market. This also stresses the immediate necessity of continuous innovation and collaboration among researchers, healthcare providers, and pharmaceutical companies to develop effective therapies and improve patient outcomes, further boosting market demand.
Download a free sample copy of the Report: https://www.marknteladvisors.com/query/request-sample/brain-cancer-therapeutics-market.html
Key Market Reports Highlights
- Market Dimensions & Projections
- Pricing Evaluation
- Recent Strategic Moves by Companies
- Primary Stakeholders
- Import/Export Trend Analysis
- Competitive Landscape Assessment
- Emerging Opportunities
- Market Trends and Indicators
*Reports Delivery Format – Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.
Browse Full Report including (TOC+ List of Table and Figures): https://www.marknteladvisors.com/research-library/brain-cancer-therapeutics-market.html
Global Brain Cancer Therapeutics Market Segmentation:
The market report categorizes the market based on different segments and geographical analysis.
Study Timeline:
-Base Year: 2024
-Historical Period: 2020 to 2023
-Forecast Period: 2025 to 2030
- By Type
- Glioblastoma -Market Size & Forecast 2020-2030, USD Million
- Meningioma-Market Size & Forecast 2020-2030, USD Million
- Pituitary Tumors-Market Size & Forecast 2020-2030, USD Million
- Others-Market Size & Forecast 2020-2030, USD Million
- By Therapy
- Chemotherapy-Market Size & Forecast 2020-2030, USD Million
- Immunotherapy-Market Size & Forecast 2020-2030, USD Million
- Targeted Therapy-Market Size & Forecast 2020-2030, USD Million
- Other-Market Size & Forecast 2020-2030, USD Million
- By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- By Region
- North America
- South America
- Europe
- The Middle East & Africa
- Asia-Pacific
Competitive Landscape
With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market companies, including – Amgen Inc., AstraZeneca PLC, Bayer AG, Kazia Therapeutics Ltd., Eisai Co., Ltd., F. Hoffmann-La Roche Ltd., GSK plc, Johnson & Johnson, Merck & Co. Inc. Novartis AG, Pfizer Inc., Bristol-Myers Squibb Company, Genentech, Inc., NantOmics, Thermo Fisher Scientific Inc. and others
Have questions? Our consultant is ready to assist: https://www.marknteladvisors.com/query/talk-to-our-consultant/brain-cancer-therapeutics-market.html
We follow a tried-and-tested research methodology that blends top-down and bottom-up approaches to deliver highly accurate market insights. Every report is powered by data triangulation, ensuring well-rounded and validated findings.
From smart sample selection and reliable data collection to in-depth analysis and precise forecasting, our process is designed to minimize error and maximize impact.
About Us –
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.
Contact Us
MarkNtel Advisors
Email: sales@marknteladvisors.com
Website: www.marknteladvisors.com
Latest Press Release – https://www.marknteladvisors.com/press-release
